Trial Summary
What is the purpose of this trial?This study aims to assess the feasibility, acceptability and preliminary effectiveness of Acceptance Commitment Therapy, in conjunction with motivation enhancement, and the use of the ChillTime App, in reducing methamphetamine use in women with MUD with or without co-occurring psychiatric disorders. This intervention is designed to be delivered remotely (e.g., participants can complete the entire study from home), with the option for in person attendance if it is not feasible or safe for participants to attend from home.
Eligibility Criteria
This trial is for women and gender non-conforming individuals with methamphetamine use disorder (MUD), who can consent, communicate in English, and have a clinician. It's not for those with severe cognitive issues, untreated psychosis, or intense suicidal thoughts needing hospitalization.Exclusion Criteria
I am able to understand and participate in the study.
Treatment Details
The study tests Acceptance Commitment Therapy combined with motivation enhancement and the ChillTime App to reduce methamphetamine use remotely. Participants can join from home unless it's unsafe or unfeasible.
1Treatment groups
Experimental Treatment
Group I: Intervention ArmExperimental Treatment1 Intervention
Participants will complete the baseline session, a 1:1 motivation building session, and 8 weeks of ACT group therapy. They will then complete a final study visit and a follow-up study visit to occur 6 month after the end of therapy.
Find a clinic near you
Research locations nearbySelect from list below to view details:
Centre for Addiction and Mental HealthToronto, Canada
Loading ...
Who is running the clinical trial?
Centre for Addiction and Mental HealthLead Sponsor